background image

Boehringer Ingelheim Clinical Trials

Find clinical trials for Boehringer Ingelheim. Search for Boehringer Ingelheim clinical trials in different cities and states across the United States.

Filter
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Halifax, Moncton, Malden MA, Methuen MA, Hamden CT,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
New

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood

for
Idiopathic Pulmonary Fibrosis
Location: The Woodlands TX
Sponsor: Boehringer Ingelheim

Sex: All

Age: 40+

Code: NCT06241560

Phase2, Recruiting
New

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

for
Chronic Kidney Disease
Location: Indianapolis IN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 2 - 17

Code: NCT07107945

Phase3, Recruiting
New

A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

for
Healthy, Hepatic Impairment
Location: San Antonio TX
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07486102

Phase1, Recruiting
New

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

for
Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities,
Location: Boston MA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 40+

Code: NCT07201922

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for
Solid Tumors
Location: New Haven CT, Hackensack NJ, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05471856

Phase1, Recruiting

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

for
Solid Tumors
Location: Morristown NJ, Winston-Salem NC, Toronto, Orlando FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05155332

Phase1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: New Haven CT, New York NY, Fairfax VA, Tamarac FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase2, Recruiting

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

for
Neuroendocrine Neoplasms
Location: Hackensack NJ, Miami FL, Pittsburgh PA, Atlanta GA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06132113

Phase1, Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

for
Kidney Disease, Chronic
Location: Halifax, Portsmouth NH, East Providence RI, Quebec,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06531824

Phase3, Recruiting